Arkolith/Insider Trading/KMTS/Form 4

Webster Brian Daniel

See Remarks, DirectorKESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) · full profile →Form 4 · filed May 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$314K
Net Open-Market Flow
-$314K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Sell(S)8K$20.53$167K342K
May 15, 2026Sell(S)7K$21.46$147K335K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-229188) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML